VCEL Vericel Corporation
Healthcare$34.97+0.69%ClosedMarket Cap: $1.79B
As of 2026-05-26
Valuation
P/E (TTM)
102.43
PEG
1.72
P/B
4.95
P/S
6.07
EV/EBITDA
52.75
DCF Value
$-17.17
FCF Yield
3.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
74.8%
Operating Margin
5.4%
Net Margin
7.3%
ROE
6.4%
ROA
4.4%
ROIC
3.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $68.4M | 72.0% | $-8.1M | $-6.3M | $— | — |
| Q4 null | $92.9M | 78.7% | $22.4M | $23.2M | $— | — |
| FY null | $276.3M | 74.4% | $11.0M | $16.5M | $— | — |
| Q3 null | $67.5M | 73.5% | $3.5M | $5.1M | $— | — |
| Q2 null | $63.2M | 73.7% | $-2.0M | $-553.0K | $— | — |
| Q1 null | $52.6M | 69.0% | $-12.8M | $-11.2M | $— | — |
| Q4 null | $75.4M | 77.6% | $18.5M | $19.8M | $— | — |
| FY null | $237.2M | 72.6% | $4.5M | $10.4M | $— | — |
| Q3 null | $57.9M | 71.9% | $-2.5M | $-901.0K | $— | — |
| Q2 null | $52.7M | 69.5% | $-6.0M | $-4.7M | $— | — |
| Q1 null | $51.3M | 68.9% | $-5.5M | $-3.9M | $— | — |
| Q4 2023 | $65.0M | 74.6% | $12.7M | $13.0M | $0.26 | — |